IE
TRIB

Israel Englander’s Trinity Biotech TRIB Stock Holding History

Israel Englander’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-103
Closed -$6.63K – 6658
2023
Q4 		$6.63K Buy
+103
New +$7.37K ﹤0.01% 5784
2022
Q2 		– Sell
-282
Closed -$45K – 7511
2022
Q1 		$45K Buy
282
+10
+4% +$1.73K ﹤0.01% 6424
2021
Q4 		$58K Sell
272
-157
-37% -$44.5K ﹤0.01% 6440
2021
Q3 		$139K Buy
+429
New +$151K ﹤0.01% 6282
2021
Q2 		– Sell
-393
Closed -$222K – 7113
2021
Q1 		$222K Sell
393
-257
-40% -$185K ﹤0.01% 5437
2020
Q4 		$372K Buy
650
+535
+465% +$266K ﹤0.01% 4426
2020
Q3 		$35 Buy
+115
New +$39.9K ﹤0.01% 4321
2020
Q2 		– Sell
-727
Closed -$120K – 4602
2020
Q1 		$120K Sell
727
-327
-31% -$51.4K ﹤0.01% 3512
2019
Q4 		$163K Buy
1,054
+21
+2% +$3K ﹤0.01% 3924
2019
Q3 		$187K Sell
1,033
-34
-3% -$8.86K ﹤0.01% 3812
2019
Q2 		$296K Buy
1,067
+34
+3% +$12.1K ﹤0.01% 3550
2019
Q1 		$441K Sell
1,033
-8
-0.8% -$3.3K ﹤0.01% 3349
2018
Q4 		$358K Sell
1,041
-56
-5% -$25.9K ﹤0.01% 3139
2018
Q3 		$658K Sell
1,097
-34
-3% -$22.2K ﹤0.01% 3096
2018
Q2 		$849K Sell
1,131
-1,230
-52% -$888K ﹤0.01% 2931
2018
Q1 		$1.82M Sell
2,361
-330
-12% -$270K ﹤0.01% 2370
2017
Q4 		$2.06M Buy
2,691
+464
+21% +$359K ﹤0.01% 2269
2017
Q3 		$1.87M Sell
2,227
-276
-11% -$231K ﹤0.01% 2201
2017
Q2 		$2.25M Sell
2,503
-19
-0.8% -$16.1K ﹤0.01% 2008
2017
Q1 		$2.25M Sell
2,522
-1,300
-34% -$1.22M ﹤0.01% 1942
2016
Q4 		$3.97M Buy
3,822
+1,713
+81% +$1.77M 0.01% 1481
2016
Q3 		$4.18M Buy
2,109
+515
+32% +$962K 0.01% 1448
2016
Q2 		$2.71M Buy
1,594
+414
+35% +$700K 0.01% 1627
2016
Q1 		$2.06M Sell
1,180
-2,307
-66% -$3.67M 0.01% 1755
2015
Q4 		$6.15M Buy
3,487
+1,936
+125% +$3.43M 0.01% 1225
2015
Q3 		$2.66M Buy
1,551
+1,216
+363% +$2.94M 0.01% 1723
2015
Q2 		$907K Sell
335
-2,120
-86% -$5.51M ﹤0.01% 2334
2015
Q1 		$7.09M Buy
2,455
+366
+18% +$1.01M 0.01% 1227
2014
Q4 		$5.49M Buy
+2,089
New +$5.4M 0.01% 1333
2014
Q3 		– Sell
-71
Closed -$244K – 4017
2014
Q2 		$244K Buy
+71
New +$252K ﹤0.01% 2996

Other funds holding TRIB

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Israel Englander's TRIB Position: Q1 2024 in Review

Israel Englander sold out of Trinity Biotech (TRIB) in Q1 2024, closing a stake of 103 shares — an estimated $6.63K sold.

Israel Englander first reported a position in TRIB in Q2 2014 and held it in 30 quarters. The position peaked at $7.09M in Q1 2015. 19 funds tracked by Wall St. Rank hold TRIB as of Q1 2024.

  • Israel Englander reported no remaining Trinity Biotech position as of Q1 2024 after selling out during the quarter.
  • Israel Englander sold 103 Trinity Biotech shares in Q1 2024, an estimated $6.63K.
  • Israel Englander first reported a position in Trinity Biotech in Q2 2014 and held it in 30 quarters.
  • Israel Englander's Trinity Biotech position peaked at $7.09M in Q1 2015.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.